GA NCORP

Doctors

O. George Negrea MD

Low Country Cancer Care Associates, PC
www.lcccsav.com

Education & Training

Specialty and Certification

Medical Oncology, Hematology / Board Certified

Clinical Trial Cancer Types

Adrenal Cancer, Bile Duct Cancer, Bladder Cancer, Bone Tumor, Brain Tumor, Breast Cancer, Cervical Cancer, Colon/Rectal Cancer, Esophogeal Cancer, Gallbladder Cancer, Gastrointestinal Stromal Tumor (GIST), Germ Cell Tumor, Gestational trophoblastic disease, Gynecologic Cancers, Head and Neck Cancer, Liver Cancer / Hepatoblastoma, Lung Cancer, Melanoma, Mesothelioma, Neuroendocrine Tumor, Ovarian Cancer, Parathyroid Cancer, Penile Cancer, Retroperitoneal Tumors, Sarcoma, Small Bowel Cancer, Solid Tumor, Stomach/ Gastric Cancer, Testicular Cancer, Thyroid Cancer, Ureter Cancer, Urethral Cancer

Affliations


Liberty Regional Medical center
Memorial University Medical Center

Active Clinical Trial Sites


Nancy N. and J.C. Lewis Cancer Research Pavilion at St. Joseph Candler

225 Candler Drive
Savannah, GA 31405
912-819-5704 (p)
www.sjchs.org

driving directions

Clinical Trials

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Adrenal Cancer

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Bile Duct Cancer

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Bladder Cancer

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Bone Tumor

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Brain Tumor

Testing the Addition of a Blood Pressure Medication, Carvedilol, to HER-2 Targeted Therapy for Metastatic Breast Cancer to Prevent Cardiac Toxicity
Cancer Type: Breast Cancer

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Cervical Cancer

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Colon/Rectal Cancer

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Esophogeal Cancer

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Gallbladder Cancer

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Gastrointestinal Stromal Tumor (GIST)

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Germ Cell Tumor

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Gestational trophoblastic disease

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Gynecologic Cancers

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Head and Neck Cancer

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Liver Cancer / Hepatoblastoma

Genetic Testing in Screening Patients with Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
Cancer Type: Lung Cancer

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Lung Cancer

Biomarker-Driven Therapy and Immunotherapy in Screening Participants with Recurrent or Stage IV Non-Small Cell Lung Cancer (The Expanded Lung-MAP Screening Trial)
Cancer Type: Lung Cancer

Testing the Use of Targeted Treatment (AMG 510) for KRAS G12C Mutated Advanced Non-squamous Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)
Cancer Type: Lung Cancer

A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients with Advanced Melanoma
Cancer Type: Melanoma

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Mesothelioma

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Neuroendocrine Tumor

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Ovarian Cancer

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Parathyroid Cancer

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Penile Cancer

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Retroperitoneal Tumors

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Sarcoma

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Small Bowel Cancer

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Solid Tumor

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Stomach/ Gastric Cancer

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Testicular Cancer

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Thyroid Cancer

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Unknown Primary

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Ureter Cancer

Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Cancer Type: Urethral Cancer
 
For a complete listing of all trial sites in Georgia, please visit GeorgiaCancerInfo.org